×
Chemed Revenue 2010-2024 | CHE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Chemed revenue for the twelve months ending December 31, 2024 was
$2.492B
, a
5.15% increase
year-over-year.
Chemed annual revenue for 2024 was
$2.431B
, a
0% decline
from 2024.
Chemed annual revenue for 2024 was
$2.431B
, a
7.37% increase
from 2023.
Chemed annual revenue for 2023 was
$2.264B
, a
0% decline
from 2023.
View More
Chemed Revenue 2010-2024 | CHE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Chemed annual revenue for 2024 was
$2.431B
, a
0% decline
from 2024.
Chemed annual revenue for 2024 was
$2.431B
, a
7.37% increase
from 2023.
Chemed annual revenue for 2023 was
$2.264B
, a
0% decline
from 2023.
Related Stocks
Company Name
Market
Cap
Fresenius SE (FSNUY)
$21.5B
Quest Diagnostics (DGX)
$19.2B
DaVita (DVA)
$12.4B
Encompass Health (EHC)
$10.2B
Elanco Animal Health (ELAN)
$5.6B
Option Care Health (OPCH)
$5.5B
RadNet (RDNT)
$4.8B
LifeStance Health (LFST)
$3.1B
Amedisys (AMED)
$3B
Astrana Health (ASTH)
$2.2B
Addus HomeCare (ADUS)
$2.1B
U.S Physical Therapy (USPH)
$1.3B
Aveanna Healthcare Holdings (AVAH)
$968M
Pennant (PNTG)
$927M
Atai Life Sciences (ATAI)
$351M
Bioqual (BIOQ)
$54M
Daxor (DXR)
$35M
Ontrak (OTRK)
$7M
MEDIROM Healthcare Technologies (MRM)
$4M
IMAC Holdings (BACK)
$1M
Psychemedics (PMD)
$0M